Solid Biosciences Stock (NASDAQ: SLDB) stock price, news, charts, stock research, profile.
You can purchase shares of Solid Biosciences (NASDAQ:SLDB) through any online brokerage.
Other companies in Solid Biosciences’s space includes: Zura Bio (NASDAQ:ZURA), Innate Pharma (NASDAQ:IPHA), Aligos Therapeutics (NASDAQ:ALGS), Adaptimmune Therapeutics (NASDAQ:ADAP) and Tevogen Bio Holdings (NASDAQ:TVGN).
Solid Biosciences has a consensus price target of $15.50.
The stock price for Solid Biosciences (NASDAQ: SLDB) is $4.2 last updated December 20, 2024 at 7:47 PM EST.
There are no upcoming dividends for Solid Biosciences.
Solid Biosciences’s Q4 earnings are confirmed for Wednesday, March 12, 2025.
There is no upcoming split for Solid Biosciences.
Solid Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.